Bristol NHS Foundation Trust

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials
• Aortic aneurysm1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Active, not recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• University College, London1 trial
• W.L.Gore & Associates1 trial

Running trials

• Recruiting

  A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

  NCT07665450· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

  NCT06658730· W.L.Gore & Associates· Source

  Contact: Marcus Brooks, Dr.

• Recruiting

  Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma

  NCT06762769· Phase 2· University College, London· Source

  Contact: Alastair Whiteway

• Recruiting

  A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  NCT05552222· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma2 recruiting
• Aortic aneurysm1 recruiting